Stockreport

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Nautilus Biotechnology, Inc.  (NAUT) 
PDF SEATTLE, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today report [Read more]